|
Post by celo on Nov 9, 2017 18:16:46 GMT -5
Mannkind is asking all the Proboards members to pick the exact weekly Afrezza sales revenue number for the week ending on Nov 3rd and win a trip to beautiful Danbury Connecticut! (Please realize that the prize is a joke and completely false!)
My guess is 372,000. Anything above the number from last week would be amazing. We probably will fall back a little.
There is no prize! Liane will nuke this thread if people actually think there is a prize!
|
|
|
Post by mytakeonit on Nov 9, 2017 18:39:46 GMT -5
Okay, I'll sit here a few minutes to watch it burn ...
|
|
|
Post by madog365 on Nov 9, 2017 18:41:41 GMT -5
Are we playing price is right rules?
|
|
|
Post by xanet on Nov 9, 2017 20:48:28 GMT -5
Mannkind is asking all the Proboards members to pick the exact weekly Afrezza sales revenue number for the week ending on Nov 3rd and win a trip to beautiful Danbury Connecticut! (Please realize that the prize is a joke and completely false!) My guess is 372,000. Anything above the number from last week would be amazing. We probably will fall back a little. There is no prize! Liane will nuke this thread if people actually think there is a prize! THIS IS SO AWESOME!!! I CAN'T BELIEVE THERE'S A PRIZE. (Now this thread will really get nuked.)
|
|
|
Post by kite on Nov 9, 2017 21:17:21 GMT -5
I will guesstimate 421K!
|
|
|
Post by dddupont on Nov 9, 2017 21:31:05 GMT -5
Aiming with a hopeful high of $434k!
|
|
|
Post by babaoriley on Nov 9, 2017 21:31:49 GMT -5
Shoot, I'll be happy with a few recycleable Dreamboats and maybe a bag of used hockey pucks!
|
|
|
Post by mytakeonit on Nov 9, 2017 21:39:50 GMT -5
Okay I'll play ... hmmm ... Nate said $27 ... so, my guess would be $502,727.27.
And kite ... how did I come up with 5-0? Ha!
|
|
|
Post by peppy on Nov 9, 2017 22:07:21 GMT -5
Mike, Pat and I are confident in reaching a low end of our revenue guidance for the second half of 2017, let me tell you why. First, Afrezza is promotionally responsive. Our sales reps now have another quarter of interactions with physicians behind them and we're further supporting this by moving marketing spend from Q1 2018 to Q4 2017 for direct to consumer TV advertising and digital marketing. Second, we expect a positive commercial impact from our label change. Third, we expect favorable pricing in mix versus Q3 of 2017. Fourth, we expect that visibility to the amount of inventory in the retail channel that will help us to further refine our recognized and deferred revenue. And lastly, our average daily shipments to wholesalers grew 26% from September to October which is reflective of increased demand being pulled through the wholesale and retail channels. Collectively these reasons enable us to feel comfortable in achieving the lower end of our revenue guidance for the second half of 2017.
In addition to this strong cartridge growth we're also seeing about a 24% increase in new writers in third quarter versus second quarter. So we believe that these are key indicators of our continued momentum and our growth with Afrezza.
500 scripts my pick. 450,000 in revenue.
|
|
|
Post by tw12 on Nov 9, 2017 22:17:04 GMT -5
512,000 (lest we forget the Halloween candy effect...)
|
|
|
Post by pantaloons on Nov 9, 2017 22:19:04 GMT -5
Mike, Pat and I are confident in reaching a low end of our revenue guidance for the second half of 2017, let me tell you why. First, Afrezza is promotionally responsive. Our sales reps now have another quarter of interactions with physicians behind them and we're further supporting this by moving marketing spend from Q1 2018 to Q4 2017 for direct to consumer TV advertising and digital marketing. Second, we expect a positive commercial impact from our label change. Third, we expect favorable pricing in mix versus Q3 of 2017. Fourth, we expect that visibility to the amount of inventory in the retail channel that will help us to further refine our recognized and deferred revenue. And lastly, our average daily shipments to wholesalers grew 26% from September to October which is reflective of increased demand being pulled through the wholesale and retail channels. Collectively these reasons enable us to feel comfortable in achieving the lower end of our revenue guidance for the second half of 2017.
In addition to this strong cartridge growth we're also seeing about a 24% increase in new writers in third quarter versus second quarter. So we believe that these are key indicators of our continued momentum and our growth with Afrezza.
500 scripts my pick. 450,000 in revenue.
Was there an explanation provided as to why the revenue guidance for the second half of 2017 is on the lower end, as opposed to middle or high? There's still nearly two months left of 2017, so perhaps it could change unexpectedly, but I am wondering why they're now projecting revenue on the low end.
|
|
|
Post by slugworth008 on Nov 9, 2017 22:21:42 GMT -5
Mike, Pat and I are confident in reaching a low end of our revenue guidance for the second half of 2017, let me tell you why. First, Afrezza is promotionally responsive. Our sales reps now have another quarter of interactions with physicians behind them and we're further supporting this by moving marketing spend from Q1 2018 to Q4 2017 for direct to consumer TV advertising and digital marketing. Second, we expect a positive commercial impact from our label change. Third, we expect favorable pricing in mix versus Q3 of 2017. Fourth, we expect that visibility to the amount of inventory in the retail channel that will help us to further refine our recognized and deferred revenue. And lastly, our average daily shipments to wholesalers grew 26% from September to October which is reflective of increased demand being pulled through the wholesale and retail channels. Collectively these reasons enable us to feel comfortable in achieving the lower end of our revenue guidance for the second half of 2017.
In addition to this strong cartridge growth we're also seeing about a 24% increase in new writers in third quarter versus second quarter. So we believe that these are key indicators of our continued momentum and our growth with Afrezza.
500 scripts my pick. 450,000 in revenue.
499 scripts 449,000 - Revenue I have no idea. Zero clue but what the heck - I'll play.
|
|
|
Post by cjm18 on Nov 9, 2017 22:39:59 GMT -5
Okay I'll play ... hmmm ... Nate said $27 ... so, my guess would be $502,727.27. And kite ... how did I come up with 5-0? Ha! Nates pps target is 27 dollars? I'll go with a 10% increase over last week. 457.6k
|
|
|
Post by cretin11 on Nov 10, 2017 5:09:13 GMT -5
I'll guess $377K
|
|
|
Post by kimi on Nov 10, 2017 5:24:17 GMT -5
Ok: 402.000 would be fine More important: NRX 305 (hopefully)
|
|